Rani Therapeutics Inc. (RANI)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

1.63

-0.95%

After-hours Dec 13, 2024, 07:11 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19
Revenue	-	-	2.72M	462.00K	979.00K
Cost of Revenue	822.00K	1.31M	-	-	-
Gross Profit	-822.00K	-1.31M	2.72M	462.00K	979.00K
Operating Income	-66.10M	-63.45M	-51.60M	-16.54M	-27.07M
Interest Income	3.30M	1.25M	89.00K	63.00K	423.00K
Pretax Income	-67.88M	-63.27M	-53.05M	-16.67M	-26.59M
Net Income	-33.97M	-63.34M	-53.09M	-16.70M	-26.60M
Selling & General & Admin	26.48M	26.84M	27.83M	4.96M	3.46M
Research & Development	39.62M	36.61M	26.48M	12.04M	24.58M
Other Expenses	-	-	-	-	-
Operating Expenses	66.10M	63.45M	54.32M	17.01M	28.04M
Interest Expense	5.08M	1.07M	466.00K	124.00K	10.00K
Selling & Marketing Expenses	-	-	-	-	-
Cost & Expenses	66.10M	63.45M	54.32M	17.01M	28.04M
Income Tax	-	70.00K	41.00K	35.00K	10.00K
Shares Outstanding (Basic)	25.50M	23.82M	19.71M	19.74M	19.74M
Shares Outstanding (Diluted)	25.50M	23.82M	19.71M	19.74M	19.74M
EPS (Basic)	-1.33	-2.66	-2.69	-0.85	-1.35
EPS (Diluted)	-1.33	-2.66	-2.69	-0.85	-1.35
EBITDA	-65.28M	-60.89M	-52.08M	-15.96M	-26.01M
Depreciation & Amortization	822.00K	1.31M	497.00K	589.00K	564.00K